Taro Shareholder Value Creation and Strategic Overview slide image

Taro Shareholder Value Creation and Strategic Overview

12 Brampton, Canada Manufacturing, Research, Marketing & Distribution Fully Compliant - Approved by FDA and Health Canada Manufactures 200+ finished dosage form pharmaceutical products Focus: semi-solids and liquids Primary product lines: ㅁ Dermatology: Rx and OTC semi-solid products ㅁ (creams, ointments and gels) and liquids Injectables and specialty products Solid-oral generic medicines Ranked #6 in the Canadian generic market ㅁ 160+ products sold in Canada 245,000+ sq. ft. manufacturing facility 500+ Employees ☐ +$136M in sales (+)
View entire presentation